BB

BB Biotech Portfolio holdings

AUM $3.98B
1-Year Est. Return 15.06%
This Quarter Est. Return
1 Year Est. Return
+15.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.1B
AUM Growth
+$165M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
26
New
Increased
Reduced
Closed

Top Buys

1
+$35.7M
2
+$30.3M
3
+$23.2M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$14M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$9.48M

Top Sells

1
+$12.9M
2
+$7.54M
3
+$5.03M
4
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
+$4.35M
5
GILD icon
Gilead Sciences
GILD
+$2.07M

Sector Composition

1 Healthcare 85.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$362M 17.22%
4,219,298
-150,000
2
$289M 13.74%
3,488,496
-25,000
3
$235M 11.17%
4,163,790
+30,000
4
$231M 10.98%
6,706,526
+405,000
5
$133M 6.32%
1,404,445
6
$116M 5.49%
2,999,412
+80,000
7
$114M 5.4%
727,428
8
$94.2M 4.47%
898,476
-41,481
9
$65.8M 3.13%
233,000
+10,000
10
$65.6M 3.12%
731,542
+95,000
11
$57.8M 2.74%
5,846,564
+205,000
12
$45.8M 2.18%
3,086,552
+90,000
13
$39.2M 1.86%
621,288
+150,000
14
$38.1M 1.81%
576,991
+459,000
15
$37.5M 1.78%
3,165,816
16
$35.7M 1.7%
+2,745,040
17
$27.8M 1.32%
933,244
-169,067
18
$23.2M 1.1%
+506,000
19
$23.1M 1.1%
558,188
+70,000
20
$21.9M 1.04%
704,582
+100,000
21
$19.2M 0.91%
1,505,737
+205,000
22
$16.2M 0.77%
2,463,522
23
$13.5M 0.64%
1,779,340
24
– –
-171,517
25
– –
-1,250,000